A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum

Vito Lorusso, C. F. Pollera, Mauro Antimi, +6

European Journal of Cancer

Surgical OncologyUrologyTransitional Cell CarcinomaUrinary TractMedicine +6

Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial

Francesco Cognetti, Enzo Maria Ruggeri, Alessandra Felici, +48

Annals of Oncology

Radical CystectomyUrologySurgical OncologyGenitourinary CancerMedicine +5

Weekly gemcitabine in advanced bladder cancer: A preliminary report from a phase I study

C. F. Pollera, A. Ceribelli, M Crecco, +1

Annals of Oncology

Urological ResearchUrologyUrologic Cancer EpidemiologyAdvanced Bladder CancerGenitourinary Cancer +6

Intraperitoneal recombinant alpha-2-interferon alternating with cisplatin as salvage therapy for minimal residual-disease ovarian cancer: a phase II study.

Marco Nardi, F. Cognetti, C. F. Pollera, +4

Journal of Clinical Oncology

Ip DdpImmunologyGynecologyPathologyPhase Ii Study +14

Very high-dose cisplatin-induced ototoxicity: a preliminary report on early and long-term effects

C. F. Pollera, Paolo Marolla, Mario Nardi, +3

Cancer Chemotherapy and Pharmacology

Long-term EffectsMedicinePreliminary ReportPharmacologyToxicology +3

Adjuvant chemotherapy (AC) with cisplatin + gemcitabine (CG) versus chemotherapy (CT) at relapse (CR) in patients (pts) with muscle-invasive bladder cancer (MIBC) submitted to radical cystectomy (RC). An Italian multicenter randomised phase III trial

F. Cognetti, Enzo Maria Ruggeri, Alessandra Felici, +7

Journal of Clinical Oncology

Radical CystectomyUrologySurgical OncologyUrological ResearchGenitourinary Cancer +12

Gemcitabine and Cisplatin in the Treatment of Elderly Patients with Advanced Non-Small Cell Lung Cancer: Impact of Comorbidities on Safety and Efficacy Outcome

Luca Moscetti, Fabrizio Nelli, D. Padalino, +3

Journal of Chemotherapy

Drug SafetyEfficacy OutcomeAdvanced NsclcGeriatric OncologyOncology +12

A feasibility study of gefitinib in association with capecitabine (CAP) and oxaliplatin (OXA) as first-line treatment in patients with advanced colorectal cancer (ACRC)

Massimo Zeuli, Alain Gelibter, C. Nardoni, +7

Journal of Clinical Oncology

Cancer ManagementCap-oxa RegimenPathologyFirst-line TreatmentPharmacotherapy +17

Changes in serum iron levels following very high-dose cisplatin

C. F. Pollera, F. Ameglio, S Reina, +3

Cancer Chemotherapy and Pharmacology

Iron MetabolismMedicineHematologyPathologyClinical Chemistry +5